201 related articles for article (PubMed ID: 24747978)
41. Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.
Weisler R; Montgomery SA; Earley WR; Szamosi J; Eriksson H
J Clin Psychiatry; 2014 May; 75(5):520-7. PubMed ID: 24816198
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.
Bortnick B; El-Khalili N; Banov M; Adson D; Datto C; Raines S; Earley W; Eriksson H
J Affect Disord; 2011 Jan; 128(1-2):83-94. PubMed ID: 20691481
[TBL] [Abstract][Full Text] [Related]
43. The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study.
Lindenmayer JP; Brown D; Liu S; Brecher M; Meulien D
Psychopharmacol Bull; 2008; 41(3):11-35. PubMed ID: 18779774
[TBL] [Abstract][Full Text] [Related]
44. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
Cutler AJ; Tran-Johnson T; Kalali A; Aström M; Brecher M; Meulien D
Psychopharmacol Bull; 2010; 43(4):37-69. PubMed ID: 21240151
[TBL] [Abstract][Full Text] [Related]
45. Cognitive Behavioral Therapy for Insomnia in Alcohol-Dependent Veterans: A Randomized, Controlled Pilot Study.
Chakravorty S; Morales KH; Arnedt JT; Perlis ML; Oslin DW; Findley JC; Kranzler HR
Alcohol Clin Exp Res; 2019 Jun; 43(6):1244-1253. PubMed ID: 30912860
[TBL] [Abstract][Full Text] [Related]
46. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
Luthringer R; Muzet M; Zisapel N; Staner L
Int Clin Psychopharmacol; 2009 Sep; 24(5):239-49. PubMed ID: 19584739
[TBL] [Abstract][Full Text] [Related]
47. Safety of low doses of quetiapine when used for insomnia.
Coe HV; Hong IS
Ann Pharmacother; 2012 May; 46(5):718-22. PubMed ID: 22510671
[TBL] [Abstract][Full Text] [Related]
48. The Relationship between Alcohol Craving and Insomnia Symptoms in Alcohol-Dependent Individuals.
He S; Brooks AT; Kampman KM; Chakravorty S
Alcohol Alcohol; 2019 May; 54(3):287-294. PubMed ID: 31087085
[TBL] [Abstract][Full Text] [Related]
49. Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data.
Locklear JC; Alemayehu B; Brody RS; Chavoshi S; Tunceli O; Kern D; Earley WR
Clin Ther; 2013 Dec; 35(12):1923-32. PubMed ID: 24275622
[TBL] [Abstract][Full Text] [Related]
50. Quetiapine in primary insomnia: a pilot study.
Wiegand MH; Landry F; Brückner T; Pohl C; Veselý Z; Jahn T
Psychopharmacology (Berl); 2008 Feb; 196(2):337-8. PubMed ID: 17922110
[No Abstract] [Full Text] [Related]
51. Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate: post-hoc analysis of data from a randomized withdrawal, placebo-controlled study.
Peuskens J; Trivedi JK; Brecher M; Miller F;
Int Clin Psychopharmacol; 2010 May; 25(3):183-7. PubMed ID: 20216222
[TBL] [Abstract][Full Text] [Related]
52. Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics.
Currie SR; Clark S; Hodgins DC; El-Guebaly N
Addiction; 2004 Sep; 99(9):1121-32. PubMed ID: 15317632
[TBL] [Abstract][Full Text] [Related]
53. Quetiapine for insomnia in Parkinson disease: results from an open-label trial.
Juri C; Chaná P; Tapia J; Kunstmann C; Parrao T
Clin Neuropharmacol; 2005; 28(4):185-7. PubMed ID: 16062098
[TBL] [Abstract][Full Text] [Related]
54. Acute anxiolytic effects of quetiapine during virtual reality exposure--a double-blind placebo-controlled trial in patients with specific phobia.
Diemer J; Domschke K; Mühlberger A; Winter B; Zavorotnyy M; Notzon S; Silling K; Arolt V; Zwanzger P
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1551-60. PubMed ID: 23375006
[TBL] [Abstract][Full Text] [Related]
55. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
[TBL] [Abstract][Full Text] [Related]
56. Annual cost of relapses and relapse-related hospitalizations in adults with schizophrenia: results from a 12-month, double-blind, comparative study of lurasidone vs quetiapine extended-release.
Rajagopalan K; O'Day K; Meyer K; Pikalov A; Loebel A
J Med Econ; 2013 Aug; 16(8):987-96. PubMed ID: 23742620
[TBL] [Abstract][Full Text] [Related]
57. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
[TBL] [Abstract][Full Text] [Related]
58. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
59. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
60. Quetiapine for insomnia: A review of the literature.
Anderson SL; Vande Griend JP
Am J Health Syst Pharm; 2014 Mar; 71(5):394-402. PubMed ID: 24534594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
